Ishaq Lat1, Craig M Coopersmith2, Daniel De Backer3, Craig M Coopersmith2. 1. Department of Pharmacy, Shirley Ryan Abilitylab, Chicago, IL, USA. ilat@sralab.org. 2. Department of Surgery and Emory Critical Care Center, Emory University, Atlanta, GA, USA. 3. Department of Intensive Care, Chirec Hospitals, Université Libre de Bruxelles, Brussels, Belgium.
Abstract
OBJECTIVE: To expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. DATA SOURCES: Original paper and literature search. STUDY SELECTION: Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy. DATA EXTRACTION: None. DATA SYNTHESIS: None. CONCLUSION: In the second of a series of manuscripts subsequent to the original paper, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.
OBJECTIVE: To expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. DATA SOURCES: Original paper and literature search. STUDY SELECTION: Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy. DATA EXTRACTION: None. DATA SYNTHESIS: None. CONCLUSION: In the second of a series of manuscripts subsequent to the original paper, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.
Authors: Simon Finfer; Rinaldo Bellomo; Neil Boyce; Julie French; John Myburgh; Robyn Norton Journal: N Engl J Med Date: 2004-05-27 Impact factor: 91.245
Authors: Pierre Asfar; Ferhat Meziani; Jean-François Hamel; Fabien Grelon; Bruno Megarbane; Nadia Anguel; Jean-Paul Mira; Pierre-François Dequin; Soizic Gergaud; Nicolas Weiss; François Legay; Yves Le Tulzo; Marie Conrad; René Robert; Frédéric Gonzalez; Christophe Guitton; Fabienne Tamion; Jean-Marie Tonnelier; Pierre Guezennec; Thierry Van Der Linden; Antoine Vieillard-Baron; Eric Mariotte; Gaël Pradel; Olivier Lesieur; Jean-Damien Ricard; Fabien Hervé; Damien du Cheyron; Claude Guerin; Alain Mercat; Jean-Louis Teboul; Peter Radermacher Journal: N Engl J Med Date: 2014-03-18 Impact factor: 91.245
Authors: Anthony J Lewis; John E Griepentrog; Xianghong Zhang; Derek C Angus; Christopher W Seymour; Matthew R Rosengart Journal: Crit Care Med Date: 2018-05 Impact factor: 7.598
Authors: Nor'azim Mohd Yunos; Rinaldo Bellomo; Colin Hegarty; David Story; Lisa Ho; Michael Bailey Journal: JAMA Date: 2012-10-17 Impact factor: 56.272
Authors: Wesley H Self; Matthew W Semler; Jonathan P Wanderer; Li Wang; Daniel W Byrne; Sean P Collins; Corey M Slovis; Christopher J Lindsell; Jesse M Ehrenfeld; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice Journal: N Engl J Med Date: 2018-02-27 Impact factor: 91.245
Authors: Ryan M Brown; Li Wang; Taylor D Coston; Nathan I Krishnan; Jonathan D Casey; Jonathan P Wanderer; Jesse M Ehrenfeld; Daniel W Byrne; Joanna L Stollings; Edward D Siew; Gordon R Bernard; Wesley H Self; Todd W Rice; Matthew W Semler Journal: Am J Respir Crit Care Med Date: 2019-12-15 Impact factor: 21.405
Authors: Mark E Nunnally; Ricard Ferrer; Greg S Martin; Ignacio Martin-Loeches; Flavia R Machado; Daniel De Backer; Craig M Coopersmith; Clifford S Deutschman Journal: Intensive Care Med Exp Date: 2021-07-02